A detailed history of Price T Rowe Associates Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Price T Rowe Associates Inc holds 254,129 shares of TEVA stock, worth $4.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
254,129
Previous 201,849 25.9%
Holding current value
$4.45 Million
Previous $2.85 Million 44.96%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $668,138 - $909,671
52,280 Added 25.9%
254,129 $4.13 Million
Q1 2024

May 15, 2024

BUY
$10.67 - $14.43 $387,267 - $523,736
36,295 Added 21.92%
201,849 $2.85 Million
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $114,491 - $149,883
14,100 Added 9.31%
165,554 $1.73 Million
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $83,028 - $118,769
11,100 Added 7.91%
151,454 $1.55 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $26,863 - $35,332
3,731 Added 2.73%
140,354 $1.06 Million
Q1 2023

May 15, 2023

BUY
$8.36 - $11.37 $100,261 - $136,360
11,993 Added 9.62%
136,623 $1.21 Million
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $46,905 - $55,932
5,900 Added 4.97%
124,630 $1.14 Million
Q3 2022

Nov 14, 2022

SELL
$6.86 - $11.95 $4.12 Million - $7.17 Million
-600,174 Reduced 83.48%
118,730 $959,000
Q2 2022

Aug 15, 2022

BUY
$7.38 - $10.4 $503,234 - $709,165
68,189 Added 10.48%
718,904 $5.41 Million
Q1 2022

May 16, 2022

BUY
$7.33 - $9.39 $850,521 - $1.09 Million
116,033 Added 21.7%
650,715 $6.11 Million
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $204,230 - $263,431
25,852 Added 5.08%
534,682 $4.28 Million
Q3 2021

Nov 15, 2021

SELL
$8.38 - $10.18 $75,420 - $91,620
-9,000 Reduced 1.74%
508,830 $4.96 Million
Q2 2021

Aug 16, 2021

BUY
$9.9 - $11.56 $4.04 Million - $4.72 Million
407,900 Added 371.05%
517,830 $5.13 Million
Q1 2021

May 17, 2021

BUY
$10.34 - $12.81 $38,258 - $47,397
3,700 Added 3.48%
109,930 $1.27 Million
Q4 2020

Feb 16, 2021

BUY
$8.61 - $11.04 $914,640 - $1.17 Million
106,230 New
106,230 $1.03 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.